2014
DOI: 10.1016/j.carbpol.2014.05.078
|View full text |Cite
|
Sign up to set email alerts
|

Effects of chitosan on oxidative stress and related factors in hemodialysis patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(18 citation statements)
references
References 24 publications
0
17
0
1
Order By: Relevance
“…As by increasing the chitosan content of HFD, in presence of calcium and vitamin supplements, significant reductions were recorded in the levels of all lipid variables in serum, except for marked elevations in HDL-C. This can be attributed to the ability of chitosan to bind lipids in the intestine impeding their absorption (Anraku et al, 2014). Moreover, the increased levels of HDL-C can enhance lipid transport to the liver for further elimination with bile acids (Abdel--Ghaffar, Ali, & Soliman, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…As by increasing the chitosan content of HFD, in presence of calcium and vitamin supplements, significant reductions were recorded in the levels of all lipid variables in serum, except for marked elevations in HDL-C. This can be attributed to the ability of chitosan to bind lipids in the intestine impeding their absorption (Anraku et al, 2014). Moreover, the increased levels of HDL-C can enhance lipid transport to the liver for further elimination with bile acids (Abdel--Ghaffar, Ali, & Soliman, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…In a study conducted on the rats that went through hemodialysis, it was found out that chitosan decreased the serum indoxyl sulphate level in 38.5% and oxidized albumin level in 15.3% compared to the control group. It is suggested that those results would promote to reduce the stress on the hemodialysis patients and would increase the total plasma antioxidant capacity at the same time [23].…”
Section: Its Antioxidant Featurementioning
confidence: 99%
“…Our recent studies suggest a new potential use for chitosan and nanofibers produced from it, as an alternative to AST-120 and as an antioxidant in CRF. Thus, from the perspective of antioxidant therapy, the use of nanofibers derived from chitosan would be preferable at a stage earlier than the conventional state of pre-dialysis uremia, where AST-120 is routinely prescribed, because such chitosanrelated products are widely used as a health food product and not a medicine [12][13][14]. It is noteworthy that another type of ampholytic polysaccharide, Sacran (Figure 1) is extracted from the Japanese indigenous Cyanobacterium Aphanothece sacrum, which is mass-aquacultured in rivers.…”
Section: Introductionmentioning
confidence: 99%